Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GeneDx Holdings Corp. - Class A Common Stock
(NQ:
WGS
)
72.07
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
127
Open
72.07
Bid (Size)
68.55 (2)
Ask (Size)
76.50 (1)
Prev. Close
72.07
Today's Range
72.07 - 72.07
52wk Range
1.320 - 89.11
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
November 19, 2024
From
GeneDx
Via
Business Wire
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
November 18, 2024
From
GeneDx
Via
Business Wire
Performance
YTD
+2629.92%
+2629.92%
1 Month
+24.71%
+24.71%
3 Month
+111.85%
+111.85%
6 Month
+265.47%
+265.47%
1 Year
+5011.35%
+5011.35%
More News
Read More
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
November 16, 2024
Via
The Motley Fool
Don’t Confuse Brains With A Bull Market, Or Price With Value
November 10, 2024
Via
Talk Markets
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts
October 16, 2024
Via
Benzinga
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics
September 19, 2024
Via
Investor's Business Daily
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
November 07, 2024
From
GeneDx
Via
Business Wire
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
November 04, 2024
From
GeneDx
Via
Business Wire
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
November 03, 2024
Via
Benzinga
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results
October 29, 2024
Via
Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
October 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 29, 2024
Via
Benzinga
Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance
October 29, 2024
Via
Benzinga
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
October 29, 2024
Via
Benzinga
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
October 29, 2024
From
GeneDx
Via
Business Wire
Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening
October 24, 2024
From
GeneDx
Via
Business Wire
GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns
October 08, 2024
From
GeneDx
Via
Business Wire
GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
October 03, 2024
From
GeneDx
Via
Business Wire
The Markets Are Ignoring Risk, But That Does Not Mean You Should...
September 29, 2024
Via
Talk Markets
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 27, 2024
From
GeneDx
Via
Business Wire
GeneDx to Participate in Fall Investor Conferences
August 12, 2024
From
GeneDx
Via
Business Wire
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From
GeneDx
Via
Business Wire
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024
July 30, 2024
Via
InvestorPlace
GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients
July 30, 2024
From
GeneDx
Via
Business Wire
GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
July 30, 2024
From
GeneDx
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.